- Home
- DFP vs ANGO Comparison
DFP vs ANGO Comparison
Compare DFP & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$13.42
Company Overview
Basic Information| Metric | DFP | ANGO |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 447.3M | 400.8M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | DFP | ANGO |
|---|---|---|
| Price | $20.89 | $13.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 56.2K | ★ 513.0K |
| Earning Date | 01-01-0001 | 01-07-2026 |
| Dividend Yield | ★ 6.73% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $300,718,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $15.45 | $8.27 |
| 52 Week High | $19.31 | $13.99 |
Technical Indicators
Market Signals| Indicator | DFP | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 37.36 | 58.95 |
| Support Level | $20.75 | $13.12 |
| Resistance Level | $21.40 | $13.70 |
| Average True Range (ATR) | 0.14 | 0.38 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 23.40 | 38.68 |
Price Performance
Historical Comparison DFP
ANGO
About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.
Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.